Investors/Media - Tenax Therapeutics

Home
About
Products
- TNX-201 (oral enteric coated imatinib)
- TNX-103 (oral levosimendan)
Education Center
Investors/Media
Contact

Search for:

Home
About
Products
- TNX-201 (oral enteric coated imatinib)
- TNX-103 (oral levosimendan)
Education Center
Investors/Media
Contact

Home
About
Products
- TNX-201 (oral enteric coated imatinib)
- TNX-103 (oral levosimendan)
Education Center
Investors/Media
Contact

Investor Information

Content Coming Soon

TO BE PROVIDED BY EXTERNAL SOURCE

Products
- TNX-201 (oral enteric coated imatinib)
- TNX-103 (oral levosimendan)
Education Center
Contact
- Email

Tenax Therapeutics

Specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension.

Privacy Policy
Terms of Service